B4GALT7 siRNA (Human)
SiRNA to inhibit B4GALT7 expression using RNA interference
Product Specifications
Product Name Alternative
XGALT1; Beta-1.4-galactosyltransferase 7; Beta-1.4-GalTase 7; Beta4Gal-T7; b4Gal-T7; UDP-Gal:beta-GlcNAc beta-1.4-galactosyltransferase 7; UDP-galactose:beta-N-acetylglucosamine beta-1.4-galactosyltransferase 7
Reactivity
H
Source
Synthetic
Applications
RNAi
Purity
> 97%
Form
Lyophilized powder
Components
We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human B4GALT7 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Specificity
B4GALT7 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
NCBI Gene Symbol
B4GALT7
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
SwissProt (Human)
Q9UBV7
Entrez GeneHuman
11285
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
